Current Concepts in Surgical Pathology 2020

Program

Download the programme in PDF
Thursday, 10 June 2021
09.00–09.30Welcome

Piotr Borkowski, MD
Quest Diagnostics

09.30–10.25Breast pathology

Esther C. Yoon, MD
MD Anderson Cancer Center

10.25–10.30Questions & answers
10.30–11.25Breast pathology

Esther C. Yoon, MD
MD Anderson Cancer Center

11.25–11.30Questions & answers
11.30–12.00Coffee break
12.00–12.55Biomarkers in breast
12.55–13.00Questions & answers
13.00–13.55Bioinformatics/molecular in breast pathology
13.55–14.00Questions & answers
14.00–15.00Lunch
15.00–15.40Management of advanced hormone receptor positive, HER2 negative breast cancer

Rachel M. Layman, MD
MD Anderson Cancer Center

15.40–15.45Questions & answers
15.45–16.25Current approaches in neoadjuvant endocrine therapy. Guiding decisions based on Ki67 and other biomarkers

Rachel M. Layman, MD
MD Anderson Cancer Center

16.25–16.30Questions & answers
16.30–17.25Malignant mesothelioma

Cesar A. Moran, MD
MD Anderson Cancer Center

17.25–17.30Questions & answers
Friday, 11 June 2021
09.00–09.55Molecular aspects of lung carcinoma

Ronald Przygodzki, MD
US Department of Veterans Affairs

09.55–10.00Questions & answers
10.00–10.55Biomarkers/bioinformatics lung carcinoma

Ronald Przygodzki, MD
US Department of Veterans Affairs

10.55–11.00Questions & answers
11.00–11.30Coffee break
11.30–12.25Treatment options in lung carcinoma

Don Lynn Gibbons, MD
MD Anderson Cancer Center

12.25–12.30Questions & answers
12.30–13.40Esophageal pathology diagnosis, molecular & bioinformatics

Dipen Maru, MD
MD Anderson Cancer Center

13.40–13.45Questions & answers
13.45–15.00Lunch
15.00–16.10Colorectal pathology. Diagnosis, molecular & bioinformatics

Dipen Maru, MD
MD Anderson Cancer Center

16.10–16.15Questions & answers
16.15–17.40Localized approaches to gastro-esophageal cancer: how can we individualize
17.40–17.45Questions & answers
17.45–18.25Advanced gastroesophageal cancers: progress and setbacks
18.25–18.30Questions & answers
Saturday, 12 June 2021
09.00–09.55Prostate cancer: diagnosis & grading

Piotr Borkowski, MD
Quest Diagnostics

09.55–10.00Questions & answers
10.00–10.40Utilizing digital pathology and artificial intelligence (A.I.) to advance precision diagnosis, work flow, productivity and personalized care in prostate diagnostics

Piotr Borkowski, MD
Quest Diagnostics

10.40–10.45Questions & answers
10.45–11.15Coffee break
11.15–11.55Prostate cancer: personalized care based on subtypes and phenotypes

Shi-Ming Tu, MD
MD Anderson Cancer Center

11.55–12.00Questions & answers
12.00–12.40Prostate cancer: drug developments vs therapy development

Shi-Ming Tu, MD
MD Anderson Cancer Center

12.40–12.45Questions & answers
12.45Farewell

Piotr Borkowski, MD
Quest Diagnostics

Thursday, 10 June 2021
09.00–09.30
Welcome

Piotr Borkowski, MD
Quest Diagnostics

09.30–10.25
Breast pathology

Esther C. Yoon, MD
MD Anderson Cancer Center

10.25–10.30
Questions & answers
10.30–11.25
Breast pathology

Esther C. Yoon, MD
MD Anderson Cancer Center

11.25–11.30
Questions & answers
11.30–12.00
Coffee break
12.00–12.55
Biomarkers in breast
12.55–13.00
Questions & answers
13.00–13.55
Bioinformatics/molecular in breast pathology
13.55–14.00
Questions & answers
14.00–15.00
Lunch
15.00–15.40
Management of advanced hormone receptor positive, HER2 negative breast cancer

Rachel M. Layman, MD
MD Anderson Cancer Center

15.40–15.45
Questions & answers
15.45–16.25
Current approaches in neoadjuvant endocrine therapy. Guiding decisions based on Ki67 and other biomarkers

Rachel M. Layman, MD
MD Anderson Cancer Center

16.25–16.30
Questions & answers
16.30–17.25
Malignant mesothelioma

Cesar A. Moran, MD
MD Anderson Cancer Center

17.25–17.30
Questions & answers
Friday, 11 June 2021
09.00–09.55
Molecular aspects of lung carcinoma

Ronald Przygodzki, MD
US Department of Veterans Affairs

09.55–10.00
Questions & answers
10.00–10.55
Biomarkers/bioinformatics lung carcinoma

Ronald Przygodzki, MD
US Department of Veterans Affairs

10.55–11.00
Questions & answers
11.00–11.30
Coffee break
11.30–12.25
Treatment options in lung carcinoma

Don Lynn Gibbons, MD
MD Anderson Cancer Center

12.25–12.30
Questions & answers
12.30–13.40
Esophageal pathology diagnosis, molecular & bioinformatics

Dipen Maru, MD
MD Anderson Cancer Center

13.40–13.45
Questions & answers
13.45–15.00
Lunch
15.00–16.10
Colorectal pathology. Diagnosis, molecular & bioinformatics

Dipen Maru, MD
MD Anderson Cancer Center

16.10–16.15
Questions & answers
16.15–17.40
Localized approaches to gastro-esophageal cancer: how can we individualize
17.40–17.45
Questions & answers
17.45–18.25
Advanced gastroesophageal cancers: progress and setbacks
18.25–18.30
Questions & answers
Saturday, 12 June 2021
09.00–09.55
Prostate cancer: diagnosis & grading

Piotr Borkowski, MD
Quest Diagnostics

09.55–10.00
Questions & answers
10.00–10.40
Utilizing digital pathology and artificial intelligence (A.I.) to advance precision diagnosis, work flow, productivity and personalized care in prostate diagnostics

Piotr Borkowski, MD
Quest Diagnostics

10.40–10.45
Questions & answers
10.45–11.15
Coffee break
11.15–11.55
Prostate cancer: personalized care based on subtypes and phenotypes

Shi-Ming Tu, MD
MD Anderson Cancer Center

11.55–12.00
Questions & answers
12.00–12.40
Prostate cancer: drug developments vs therapy development

Shi-Ming Tu, MD
MD Anderson Cancer Center

12.40–12.45
Questions & answers
12.45
Farewell

Piotr Borkowski, MD
Quest Diagnostics

Organizer:
Via Medica
Media patronage :
Via Medica
Partner:
Via Medica

Strony konferencji Grupy Via Medica wykorzystują pliki cookies. Opcje dotyczące cookies można zmienić w ustawieniach przeglądarki internetowej.
Korzystanie z niniejszej strony bez zmiany ustawień dotyczących cookies oznacza, że będą one zapisane w pamięci komputera. Czym są i do czego służą pliki cookie możesz dowiedzieć się na stronie www.wszystkoociasteczkach.pl

Copyright © 2019 Via Medica | Kariera w Grupie Via Medica